Does OLAPARIB Cause Leukaemia? 76 Reports in FDA Database
Prostate Health & Male Vitality — Naturally
ProstaVive: better flow, better sleep, better energy. 180-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 76 reports of Leukaemia have been filed in association with OLAPARIB (Lynparza). This represents 0.4% of all adverse event reports for OLAPARIB.
76
Reports of Leukaemia with OLAPARIB
0.4%
of all OLAPARIB reports
18
Deaths
16
Hospitalizations
How Dangerous Is Leukaemia From OLAPARIB?
Of the 76 reports, 18 (23.7%) resulted in death, 16 (21.1%) required hospitalization, and 10 (13.2%) were considered life-threatening.
Is Leukaemia Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for OLAPARIB. However, 76 reports have been filed with the FAERS database.
What Other Side Effects Does OLAPARIB Cause?
Death (4,378)
Malignant neoplasm progression (1,862)
Nausea (1,582)
Anaemia (1,455)
Fatigue (1,437)
Off label use (777)
Vomiting (642)
Drug ineffective (563)
Diarrhoea (514)
Asthenia (491)
What Other Drugs Cause Leukaemia?
RANITIDINE (1,040)
VENETOCLAX (385)
RUXOLITINIB (321)
IMATINIB (242)
ADALIMUMAB (239)
LENALIDOMIDE (219)
NILOTINIB (176)
CLOZAPINE (156)
METHOTREXATE (142)
ETANERCEPT (139)
Which OLAPARIB Alternatives Have Lower Leukaemia Risk?
OLAPARIB vs OLARATUMAB
OLAPARIB vs OLECLUMAB
OLAPARIB vs OLIVE OIL\SOYBEAN OIL
OLAPARIB vs OLMESARTAN
OLAPARIB vs OLMESARTAN MEDOXOMIL